Sylvia Selhofer

Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis*

Thomas Graier, Wolfgang Salmhofer, Constanze Jonak et al. · British Journal of Dermatology · 2020 · 64 citations · Full text

Medicine, Immunology, Pharmacotherapy +14

Evaluation of Low-Dose, Low-Frequency Oral Psoralen–UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides

Pablo Vieyra-Garcia, Regina Fink‐Puches, Stefanie Porkert et al. · JAMA Dermatology · 2019 · 51 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria

Martin Inzinger, Katharina Wippel‐Slupetzky, Wolfgang Weger et al. · Acta Dermato Venereologica · 2015 · 40 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Comparison of topical benzyl benzoate vs. oral ivermectin in treating scabies: A randomized study

Damian Meyersburg, Tobias Welponer, Andreas Kaiser et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 25 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +16

Quality of Life, Anxiety, and Depression in Patients With Early-Stage Mycosis Fungoides and the Effect of Oral Psoralen Plus UV-A (PUVA) Photochemotherapy on it

Thomas Graier, Regina Fink‐Puches, S. Porkert et al. · Frontiers in Medicine · 2020 · 18 citations · Full text

Medicine, Dermatology, Health Sciences +16